Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

Log in / Sign up

← Back to home

Shanghai Kanda Biotechnology Co., Ltd.

Clinical trials sponsored by Shanghai Kanda Biotechnology Co., Ltd., explained in plain language.

New RA drug KD6005 enters first human tests

Disease control Completed

This early-stage study tested a new drug called KD6005 in 73 people. First, healthy volunteers received a single dose to check safety. Then, people with rheumatoid arthritis received multiple doses. The main goal was to see if the drug is safe and how the body processes it. This …

Phase: PHASE1 • Sponsor: Shanghai Kanda Biotechnology Co., Ltd. • Aim: Disease control

Last updated May 26, 2026 07:22 UTC